Sort
15,842 grants matching “pancreatic cancer”
Synthesis of Anticancer Pyran Natural Products
$275,633Karl A Scheidt · Northwestern University · R01 · FY2009 · CA
Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
$275,630Mark A. Mc Niven · Mayo Clinic Rochester · R01 · FY2012 · CA
Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
$275,630Mark A. Mc Niven · Mayo Clinic Rochester · R01 · FY2011 · CA
Role of Inflammation in the Development and Progression of Pancreatic Cancer
$275,615Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Animal model of Pancreatic Cancer
$275,615Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Combination therapy using tumor-targeting synthetic dsRNA and gemcitabine
$275,583Zhengrong Cui · University Of Texas At Austin · R01 · FY2009 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$275,576Andrew M Lowy · University Of California, San Diego · R01 · FY2015 · CA
The Inhibition of HSP70 Induces Apoptosis in Pancreatic Cancer Cells
$275,529Ashok K Saluja · University Of Minnesota · R01 · FY2011 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$275,452Andrew M Lowy · University Of California, San Diego · R01 · FY2013 · CA
Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach
$275,271Animesh Dhar · University Of Kansas Medical Center · R01 · FY2011 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$275,270Andrew M Lowy · University Of California, San Diego · R01 · FY2014 · CA
Synthesis of Anticancer Pyran Natural Products
$275,174Karl A Scheidt · Northwestern University · R01 · FY2010 · CA
CORE--CELL BANK/IMMUNOLOGY
$275,139Columbia University Health Sciences · P30 · FY2003 · DK
Keratin 19 and Pancreatic Ductal Biology
$275,102University Of Pennsylvania · R01 · FY2002 · DK
SBIR Phase I: Cell-penetrating monobodies targeting oncogenic KRAS
$275,000Johnathan D Rabb · Covalabio Inc. · · FY2024 · TIP
STTR Phase I: Hand-Held Induction Heaters for Pancreatic and Prostatic Cancer Treatment
$275,000Jorge L Castro Torres · Ihnnova Llc · · FY2024 · TIP
The Role of MicroRNAs in Cellular Quiescence
$274,950Hilary A Coller · Princeton University · R01 · FY2011 · GM
Mesothelin as biomarker and therapeutic target
$274,911Ingegerd E. Hellstrom · University Of Washington · R01 · FY2009 · CA
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
$274,889Amato J. Giaccia · Stanford University · P01 · FY2009 · CA
PDX-1 is a Therapeutic Target for Pancreatic Cancer
$274,814Francis Charles Brunicardi · Baylor College Of Medicine · R01 · FY2010 · CA
PDX-1 is a Therapeutic Target for Pancreatic Cancer
$274,814Francis Charles Brunicardi · Baylor College Of Medicine · R01 · FY2008 · CA
PDX-1 is a Therapeutic Target for Pancreatic Cancer
$274,814Francis Charles Brunicardi · Baylor College Of Medicine · R01 · FY2009 · CA
SBIR Phase I: Development of a SERS-based diagnostic platform for multiplexing ubiquitous inflammatory markers in cancer.
$274,750Mini Thomas · Amplified Sciences, Llc · · FY2024 · TIP
Cancer Epigenetics Training Program
$274,719Maria Eugenia Figueroa · University Of Miami School Of Medicine · T32 · FY2021 · CA
Core 1: Biospecimen and Pathology Core
$274,654Dipen M. Maru · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA